The company received positive analyst coverage, with both BTIG and UBS reiterating Buy ratings and setting price targets of $264 and $270 respectively. It was described as an affordable blue-chip stock. The company is also seeing rising net interest income and has a significant deal with Discover in progress. However, there are concerns about cash flow growth, and insiders were net sellers of the stock over the past year, with 17 insider holdings recently sold.